動画検索
関連広告
検索結果
Daniel George, MD; Walter Stadler, MD; Toni Choueiri, MD; Richard W. Joseph, MD; and Robert J. Amato, DO, compare data regarding first-line ...
YouTube-OncLiveTV
2018/08/07Primo N. Lara, MD, associate director for translational research, UC Davis Comprehensive Cancer Center, discusses the role of sunitinib ...
YouTube-OncLiveTV
2017/08/02Michael Atkins, MD, from the Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, discusses recent trials in the treatment of ...
YouTube-VJOncology
2017/09/25Michael C. Heinrich, MD, OHSU Knight Cancer Institute, Portland, OR, provides an overview of the rationale and results of the multicenter, ...
YouTube-VJOncology
2022/06/05Daniel J. George, MD, director, GU Oncology, Duke Cancer Institute, discusses using sunitinib to treat patients with renal cell carcinoma ...
YouTube-OncLiveTV
2013/10/10... sunitinib and a high rate of toxic effects. Full trial results: http://nej.md/2GaYWq9 Watch more Quick Take videos: http://nej.md/quick-take.
YouTube-NEJM Group
2018/04/05Robert Figlin, MD, and Nizar Tannir, MD, FACP, examine data comparing tyrosine kinase inhibitors (TKIs), pazopanib with sunitinib, in renal ...
YouTube-OncLiveTV
2016/02/04動画の見どころ1/7枚目 How to choose therapy and when to start therapy in renal cell carcinoma?
動画の見どころ2/7枚目 What was the rationale for this phase 3 trial?
動画の見どころ3/7枚目 The COMPARISON trial
動画の見どころ4/7枚目 COMPAS trial
動画の見どころ5/7枚目 Safety
動画の見どころ6/7枚目 Patient preference
動画の見どころ7/7枚目 What is the preferred schedule for sunitinib?
Robin Jones, MBBS, MRCP, MD, The Royal Marsden Hospital, London, UK, provides an overview of findings from the Phase III INTRIGUE trial ...
YouTube-VJOncology
2023/06/04Prof Janet Brown talks to ecancer about the STAR trial. A Randomised multi-stage phase II/III trial of standard first-line therapy ...
ecancer
2021/09/21Study findings on pembrolizumab plus axitinib vs sunitinib as first-line therapy for locally advanced or metastatic renal cell carcinoma.
Facebook-The ASCO Post
2019/02/21... sunitinib with extended 25.4 mo minimum (32.9 mo median) follow-up. This exploratory analysis evaluated the relationship between DepOR and ...
ecancer
2022/06/07Thomas Powles, MBBS, MRCP, MD, Barts Cancer Institute, London, UK, outlines KEYNOTE-426 (NCT02853331), a study that evaluated the efficacy ...
YouTube-VJOncology
2020/06/01, investigating nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma (RCC). This study ...
YouTube-VJOncology
2021/03/30動画の見どころ1/7枚目 What are the patterns of progression?
動画の見どころ2/7枚目 What did the study show?
動画の見どころ3/7枚目 Categorizing patients by patterns of progression
動画の見どころ4/7枚目 New lesion progression with nivolumab plus ipilimumab
動画の見どころ5/7枚目 Brain metastases progression
動画の見どころ6/7枚目 Final conclusions
動画の見どころ7/7枚目 Final thoughts
Pronunciation flashcards for the print, e-book, and pharmacology audiobook Memorizing Pharmacology: A Relaxed Approach.
YouTube-Tony PharmD
2016/08/18... sunitinib for treating patients with renal cell carcinoma, providing a follow-up to the CheckMate 9ER trial. Add comment. Efficacy of ...
Vimeo-HMP
2023/04/18PhD, on Renal Cell Carcinoma: New Data on. Pembrolizumab Plus Axitinib vs Sunitinib as First-Line Therapy. Jonathan E. Rosenberg, MD, and Thomas ...
Facebook-The ASCO Post
2022/06/10A gel-forming sustained-delivery eye drop containing the drug sunitinib, could provide increased intraocular absorption of the drug while ...
Facebook-Glaucoma Australia
2023/01/29Brian I. Rini, MD, on #RenalCellCarcinoma: Data on Atezolizumab, Bevacizumab, and Sunitinib #RCC #kidneycancer.
Facebook-The ASCO Post
2021/04/14Elshad Hasanov MD interviews Eric Jonasch MD on Lenvatinib and Pembrolizumab Compared to Sunitinib for Advanced Renal Cell Carcinoma Video ...
YouTube-PracticeUpdate
2021/04/30Share your videos with friends, family, and the world.
YouTube-Oncotutos SFPO
2018/07/05